Page last updated: 2024-10-26

dipyridamole and Eperythrozoonosis

dipyridamole has been researched along with Eperythrozoonosis in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"A case of thrombotic thrombocytopenic purpura in which sustained remission followed splenectomy is described."1.26Thrombotic thrombocytopenic purpura--remission following splenectomy. Report of a case and review of the literature. ( Brine, JA; Jackson, JM; Reynolds, PM; Vivian, AB, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reynolds, PM1
Jackson, JM1
Brine, JA1
Vivian, AB1

Other Studies

1 other study available for dipyridamole and Eperythrozoonosis

ArticleYear
Thrombotic thrombocytopenic purpura--remission following splenectomy. Report of a case and review of the literature.
    The American journal of medicine, 1976, Volume: 61, Issue:3

    Topics: Adolescent; Aspirin; Dipyridamole; Humans; Male; Mycoplasma Infections; Purpura, Thrombotic Thromboc

1976